{"nct_id":"NCT06295809","title":"A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2024-04-18","start_date_type":"ACTUAL","primary_completion_date":"2026-03-05","primary_completion_date_type":"ESTIMATED","completion_date":"2026-03-05","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["MRK"]}